The Role of 4-IBB in T Cell and APC Interactions

4-IBB 在 T 细胞和 APC 相互作用中的作用

基本信息

  • 批准号:
    7028988
  • 负责人:
  • 金额:
    $ 32.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-04-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a revised application for continuation of a grant to study regulation of T cell responses by costimulatory members of the TNFR family. Our continued efforts will examine the role and function of 4-1BB (CD137) in driving the generation and persistence of CD4 and CD8 memory. The hypothesis behind these studies is that 4-1BB signals promote clonal expansion and accumulation of T cells, in part by regulating T cell proliferation and in part by suppressing apoptosis. We will investigate the function of 4-1BB using several in-vivo systems, tracking OT-I CD8 and OT-II CD4 transgenic T cells when 4-1BBL is blocked, and when 4-1BB is absent, using T cells from transgenic mice crossed to 4-1BB-/- mice. We will investigate the contribution of 4-1BB signals to memory generation and longevity under conditions of varying inflammation, including Type 1 and Type 2 cytokine responses. In addition, we will show how 4-1BB/4-1BBL interactions are favored and whether there is differential use by CD4 cells, CD8 cells, or non-T cells. Lastly, memory in secondary lymphoid organs will be compared to peripheral memory responses associated with lung inflammation. T cell costimulation is becoming an ever increasingly complicated subject with more and more molecules being defined that may positively regulate a T cell. We think this plethora of molecules will ultimately be explained in several ways. One is a quantitative model, in that several molecules will perform the same function at the same time, but with each being absolutely essential to the T cell. Another is a kinetic model, where several molecules will work in a temporal fashion, one after the other, at different times in the lifespan of a responding T cell. Lastly, as antigen-reacting T cells differentiate and become long-lived, their requirements and/or usage of costimulatory molecules will change. This application will aid in delineating the role of one member of the TNFR family in generating and maintaining T cell memory over time. We believe these studies will provide a framework for a model of costimulation that incorporates multiple receptor/ligand interactions. Moreover, it will aid in defining how T cell responses can be effectively targeted for vaccination or therapeutic purposes depending on the type of T cell and the stage in the life of the T cell.
描述(由申请人提供):这是一份修订后的申请,用于继续研究TNFR家族共刺激成员对T细胞应答的调节。我们将继续努力研究4-1BB(CD 137)在驱动CD 4和CD 8记忆的产生和持久性中的作用和功能。这些研究背后的假设是,4-1BB信号促进T细胞的克隆扩增和积累,部分通过调节T细胞增殖,部分通过抑制凋亡。我们将使用几种体内系统研究4-1BB的功能,当4-1BBL被阻断时,以及当4 -1BB不存在时,使用来自与4-1BB-/-小鼠杂交的转基因小鼠的T细胞追踪OT-I CD 8和OT-II CD 4转基因T细胞。我们将研究4-1BB信号在不同炎症条件下对记忆产生和寿命的贡献,包括1型和2型细胞因子反应。此外,我们将展示4-1BB/4-1BBL相互作用是如何受到青睐的,以及CD 4细胞、CD 8细胞或非T细胞是否存在差异使用。最后,将次级淋巴器官中的记忆与肺部炎症相关的外周记忆反应进行比较。 T细胞共刺激正成为一个越来越复杂的课题,越来越多的分子被定义为可以正向调节T细胞。我们认为,这种过多的分子最终将在几个方面得到解释。一种是定量模型,即几种分子将同时执行相同的功能,但每种分子对T细胞都是绝对必要的。另一个是动力学模型,其中几个分子将以时间的方式工作,一个接一个,在响应T细胞寿命的不同时间。最后,随着抗原反应性T细胞分化并变得长寿,它们对共刺激分子的需求和/或使用将改变。这个应用程序将有助于描述TNFR家族的一个成员在产生和维持T细胞记忆中的作用。我们相信,这些研究将提供一个框架的共刺激模型,包括多个受体/配体相互作用。此外,它将有助于定义如何根据T细胞的类型和T细胞的生命阶段有效地靶向T细胞应答以用于疫苗接种或治疗目的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Croft其他文献

Michael Croft的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Croft', 18)}}的其他基金

TWEAK and Skin Inflammation
调整和皮肤炎症
  • 批准号:
    10400699
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
Treg 细胞固有的 CTLA4-PKC-eta 信号通路介导接触依赖性肿瘤免疫抑制:癌症免疫治疗的新靶点
  • 批准号:
    10531229
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
Immune Regulation by Deubiquitination
通过去泛素化进行免疫调节
  • 批准号:
    9982199
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
Treg 细胞固有的 CTLA4-PKC-eta 信号通路介导接触依赖性肿瘤免疫抑制:癌症免疫治疗的新靶点
  • 批准号:
    10053328
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
TWEAK and Skin Inflammation
调整和皮肤炎症
  • 批准号:
    9910059
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy
Treg 细胞固有的 CTLA4-PKC-eta 信号通路介导接触依赖性肿瘤免疫抑制:癌症免疫治疗的新靶点
  • 批准号:
    10310411
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
TWEAK and Skin Inflammation
调整和皮肤炎症
  • 批准号:
    10152528
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
Immune Regulation by Deubiquitination
通过去泛素化进行免疫调节
  • 批准号:
    9788250
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
Training in Immunological Mechanisms
免疫机制培训
  • 批准号:
    9321444
  • 财政年份:
    2016
  • 资助金额:
    $ 32.43万
  • 项目类别:
Training in Immunological Mechanisms
免疫机制培训
  • 批准号:
    10675443
  • 财政年份:
    2016
  • 资助金额:
    $ 32.43万
  • 项目类别:

相似海外基金

Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
癌症中 CD8 T 细胞耗竭的抗原呈递细胞控制
  • 批准号:
    10659843
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
Regulation of Antitumor T-cell repertoire responses by antigen presenting cell subsets
抗原呈递细胞亚群调节抗肿瘤 T 细胞库反应
  • 批准号:
    23H02706
  • 财政年份:
    2023
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a novel artificial antigen presenting cell to study human CD8 T cell biology
开发新型人工抗原呈递细胞来研究人类 CD8 T 细胞生物学
  • 批准号:
    574458-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 32.43万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of a novel artificial antigen presenting cell to study human CD8 T cell biology
开发新型人工抗原呈递细胞来研究人类 CD8 T 细胞生物学
  • 批准号:
    564338-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 32.43万
  • 项目类别:
    University Undergraduate Student Research Awards
Molecular mechanisms on antigen presenting cell function and generation
抗原呈递细胞功能和生成的分子机制
  • 批准号:
    20H03505
  • 财政年份:
    2020
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Preserving T cell / antigen presenting cell interactions via shared L-arginine
通过共享 L-精氨酸保留 T 细胞/抗原呈递细胞相互作用
  • 批准号:
    10240447
  • 财政年份:
    2020
  • 资助金额:
    $ 32.43万
  • 项目类别:
Lung Megakaryocytes Are A Novel Professional Antigen Presenting Cell
肺巨核细胞是一种新型专业抗原呈递细胞
  • 批准号:
    9759173
  • 财政年份:
    2019
  • 资助金额:
    $ 32.43万
  • 项目类别:
Antigen presenting cell mediated regulation of intestinal inflammation
抗原呈递细胞介导的肠道炎症调节
  • 批准号:
    18K15128
  • 财政年份:
    2018
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Epithelial cell-antigen presenting cell crosstalk in the maintenance of immune homeostasis in the lung
上皮细胞-抗原呈递细胞串扰维持肺免疫稳态
  • 批准号:
    1640539
  • 财政年份:
    2015
  • 资助金额:
    $ 32.43万
  • 项目类别:
    Studentship
The role of GCN2-kinase in antigen presenting cell function and tolerance to self
GCN2激酶在抗原呈递细胞功能和自身耐受性中的作用
  • 批准号:
    8662697
  • 财政年份:
    2013
  • 资助金额:
    $ 32.43万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了